These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 16122626)

  • 1. A novel approach to identify Duchenne muscular dystrophy patients for aminoglycoside antibiotics therapy.
    Kimura S; Ito K; Miyagi T; Hiranuma T; Yoshioka K; Ozasa S; Matsukura M; Ikezawa M; Matsuo M; Takeshima Y; Miike T
    Brain Dev; 2005 Sep; 27(6):400-5. PubMed ID: 16122626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequence specificity of aminoglycoside-induced stop condon readthrough: potential implications for treatment of Duchenne muscular dystrophy.
    Howard MT; Shirts BH; Petros LM; Flanigan KM; Gesteland RF; Atkins JF
    Ann Neurol; 2000 Aug; 48(2):164-9. PubMed ID: 10939566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations.
    Wagner KR; Hamed S; Hadley DW; Gropman AL; Burstein AH; Escolar DM; Hoffman EP; Fischbeck KH
    Ann Neurol; 2001 Jun; 49(6):706-11. PubMed ID: 11409421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gentamicin fails to increase dystrophin expression in dystrophin-deficient muscle.
    Dunant P; Walter MC; Karpati G; Lochmüller H
    Muscle Nerve; 2003 May; 27(5):624-7. PubMed ID: 12707984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of dystrophin mRNA from skeletal muscle but not from lymphocytes led to identification of a novel nonsense mutation in a carrier of Duchenne muscular dystrophy.
    Ito T; Takeshima Y; Yagi M; Kamei S; Wada H; Nakamura H; Matsuo M
    J Neurol; 2003 May; 250(5):581-7. PubMed ID: 12736738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein- and mRNA-based phenotype-genotype correlations in DMD/BMD with point mutations and molecular basis for BMD with nonsense and frameshift mutations in the DMD gene.
    Deburgrave N; Daoud F; Llense S; Barbot JC; Récan D; Peccate C; Burghes AH; Béroud C; Garcia L; Kaplan JC; Chelly J; Leturcq F
    Hum Mutat; 2007 Feb; 28(2):183-95. PubMed ID: 17041906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD.
    McClorey G; Moulton HM; Iversen PL; Fletcher S; Wilton SD
    Gene Ther; 2006 Oct; 13(19):1373-81. PubMed ID: 16724091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Readthrough of dystrophin stop codon mutations induced by aminoglycosides.
    Howard MT; Anderson CB; Fass U; Khatri S; Gesteland RF; Atkins JF; Flanigan KM
    Ann Neurol; 2004 Mar; 55(3):422-6. PubMed ID: 14991821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gentamicin-induced readthrough of stop codons in Duchenne muscular dystrophy.
    Malik V; Rodino-Klapac LR; Viollet L; Wall C; King W; Al-Dahhak R; Lewis S; Shilling CJ; Kota J; Serrano-Munuera C; Hayes J; Mahan JD; Campbell KJ; Banwell B; Dasouki M; Watts V; Sivakumar K; Bien-Willner R; Flanigan KM; Sahenk Z; Barohn RJ; Walker CM; Mendell JR
    Ann Neurol; 2010 Jun; 67(6):771-80. PubMed ID: 20517938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Suppression of nonsense mutations in the Dystrophin gene by a suppressor tRNA gene].
    Kiselev AV; Ostapenko OV; Rogozhkina EV; Kholod NS; Seit Nebi AS; Baranov AN; Lesina EA; Ivashchenko TE; Sabetskiĭ VA; Shavlovskiĭ MM; Rechinskiĭ VO; Kiselev LL; Baranov VC
    Mol Biol (Mosk); 2002; 36(1):43-7. PubMed ID: 11862712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapy.
    Gurvich OL; Tuohy TM; Howard MT; Finkel RS; Medne L; Anderson CB; Weiss RB; Wilton SD; Flanigan KM
    Ann Neurol; 2008 Jan; 63(1):81-9. PubMed ID: 18059005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. By-passing the nonsense mutation in the 4 CV mouse model of muscular dystrophy by induced exon skipping.
    Mitrpant C; Fletcher S; Iversen PL; Wilton SD
    J Gene Med; 2009 Jan; 11(1):46-56. PubMed ID: 19006096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice.
    Barton-Davis ER; Cordier L; Shoturma DI; Leland SE; Sweeney HL
    J Clin Invest; 1999 Aug; 104(4):375-81. PubMed ID: 10449429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion mutations in the dystrophin gene of Saudi patients with Duchenne and Becker muscular dystrophy.
    Al-Jumah M; Majumdar R; Al-Rajeh S; Chaves-Carballo E; Salih MM; Awada A; Al-Shahwan S; Al-Uthaim S
    Saudi Med J; 2002 Dec; 23(12):1478-82. PubMed ID: 12518196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphism in muscle biopsies of Duchenne and Becker muscular dystrophy patients.
    Anand A; Prabhakar S; Kaul D
    Neurol India; 1999 Sep; 47(3):218-23. PubMed ID: 10514583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic Diagnosis and Molecular Therapies for Duchenne Muscular Dystrophy].
    Takeshima Y
    Rinsho Byori; 2015 Oct; 63(10):1194-201. PubMed ID: 26897856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A highly functional mini-dystrophin/GFP fusion gene for cell and gene therapy studies of Duchenne muscular dystrophy.
    Li S; Kimura E; Ng R; Fall BM; Meuse L; Reyes M; Faulkner JA; Chamberlain JS
    Hum Mol Genet; 2006 May; 15(10):1610-22. PubMed ID: 16595609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negamycin restores dystrophin expression in skeletal and cardiac muscles of mdx mice.
    Arakawa M; Shiozuka M; Nakayama Y; Hara T; Hamada M; Kondo S; Ikeda D; Takahashi Y; Sawa R; Nonomura Y; Sheykholeslami K; Kondo K; Kaga K; Kitamura T; Suzuki-Miyagoe Y; Takeda S; Matsuda R
    J Biochem; 2003 Nov; 134(5):751-8. PubMed ID: 14688241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long mutant dystrophins and variable phenotypes: evasion of nonsense-mediated decay?
    Kerr TP; Sewry CA; Robb SA; Roberts RG
    Hum Genet; 2001 Oct; 109(4):402-7. PubMed ID: 11702221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of Duchenne muscular dystrophy with gentamicin].
    Matsuo M; Takeshima Y; Yagi M; Ishibashi K; Wada H
    No To Hattatsu; 2004 Mar; 36(2):125-9. PubMed ID: 15031986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.